Identification of the Epigenetic Reader BRD4 As a Novel Therapeutic Target in JAK2 V617F+MPN Cells

被引:0
|
作者
Keller, Alexandra [1 ,2 ]
Peter, Barbara [1 ,2 ]
Zuber, Johannes [3 ]
Staber, Philipp Bernhard [2 ]
Bettelheim, Peter [4 ]
Valent, Peter [1 ,2 ]
Hadzijusufovic, Emir [1 ,2 ,5 ]
机构
[1] Med Univ Vienna, Ludwig Boltzmann Cluster Oncol, Vienna, Austria
[2] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med 1, Vienna, Austria
[3] Res Inst Mol Pathol IMP, Vienna, Austria
[4] Elisabethinen Hosp, Dept Med 1, Linz, Austria
[5] Univ Vet Med Vienna, Internal Med, Small Anim Clin, Dept Compan Anim & Horses, Vienna, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] JAK2 V617F HAEMATOPOIETIC CLONES WITH DIFFERENT EXPANSION KINETICS ARE DETECTABLE SEVERAL YEARS PRIOR TO MPN DIAGNOSIS
    Mckerrell, T.
    Park, N.
    Chi, J.
    Collord, G.
    Moreno, T.
    Ponstingl, H.
    Dias, Joao M. L.
    Gerasimou, P.
    Melanthiou, K.
    Prokopiou, C.
    Antoniades, M.
    Varela, I.
    Costeas, P.
    Vassiliou, G.
    HAEMATOLOGICA, 2017, 102 : 149 - 149
  • [32] RARE MDS/MPN OVERLAP: WHEN JAK2 V617F MEETS DEL(5Q) MUTATION
    Rupoli, S.
    Morsia, E.
    Goteri, G.
    Capelli, D.
    Scortechini, A. R.
    Poloni, A.
    Micucci, G.
    Garvey, K. B.
    Ceglie, S.
    Fiorentini, A.
    Angelini, M.
    Mancini, S.
    Discepoli, G.
    Viola, N.
    Olivieri, A.
    HAEMATOLOGICA, 2019, 104 : 170 - 170
  • [33] JAK2 mutations other than V617F: A novel mutation and mini review
    Karow, Axel
    Waller, Cornelius
    Reimann, Christian
    Niemeyer, Charlotte M.
    Kratz, Christian P.
    LEUKEMIA RESEARCH, 2008, 32 (02) : 365 - 366
  • [34] Treatment in Vitro with a Combination of Bcl-Xl Inhibitor-ABT-737 and a JAK2 Inhibitor Selectively Eliminates JAK2V617F MPN Progenitor Cells
    Lu, Min
    Zhang, Wei
    Wang, Jiapeng
    Li, Yan
    Wang, Xiaoli
    Yoo, Daniel
    Austin, Adam
    Mascarenhas, John
    Zhao, Zhizhuang Joe
    Hoffman, Ronald
    Xu, Mingjiang
    BLOOD, 2009, 114 (22) : 313 - 313
  • [35] Depletion of Jak2V617F MPN Stem Cells by IFNα in a Murine Model of Polycythemia Vera
    Mullally, Ann
    Bruedigam, Claudia
    Heckl, Dirk
    Poveromo, Luke
    Heidel, Florian H.
    Hill, Geoff
    Ebert, Benjamin L.
    Lane, Steven W.
    BLOOD, 2012, 120 (21)
  • [36] An Inhibitor of TGF-β Promotes Proliferation of Normal but Not MPN Hematopoietic Cells and Is a Candidate Therapeutic Agent for the Treatment of MPN Patients Carrying JAK2 V617F or Calr pQ365fs Mutations
    Migliaccio, Anna Rita
    Iancu-Rubin, Camelia
    Weinberg, Rona Singer
    Hoffman, Ronald
    Dueck, Amylou Constance
    Mascarenhas, John O.
    BLOOD, 2015, 126 (23)
  • [37] JAK2 V617F Mutation in Endothelial Cells of Patients with Atherosclerotic Carotid Disease
    Diz-Kucukkaya, Reyhan
    Iyigun, Taner
    Albayrak, Ozgur
    Eker, Candan
    Gunel, Tuba
    TURKISH JOURNAL OF HEMATOLOGY, 2024, 41 (03) : 167 - 174
  • [38] Effects of CYT387, a Potent Novel JAK2 Inhibitor on JAK2-V617F Induced MPD
    Bumm, Thomas G. P.
    Tyner, Jeffrey W.
    Deininger, Jutta
    Loriaux, Marc
    VanDyke, Jonathan
    Druker, Brian J.
    Burns, Christopher J.
    Fantino, Emmanuelle
    Deininger, Michael W. N.
    BLOOD, 2008, 112 (11) : 316 - 317
  • [39] Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients
    C M Butcher
    U Hahn
    L B To
    J Gecz
    E J Wilkins
    H S Scott
    P G Bardy
    R J D'Andrea
    Leukemia, 2008, 22 : 870 - 873
  • [40] Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients
    Butcher, C. M.
    Hahn, U.
    To, L. B.
    Gecz, J.
    Wilkins, E. J.
    Scott, H. S.
    Bardy, P. G.
    D'Andrea, R. J.
    LEUKEMIA, 2008, 22 (04) : 870 - 873